Berdyński Mariusz, Kuźma-Kozakiewicz Magdalena, Ricci Claudia, Kubiszewska Justyna, Millecamps Stéphanie, Salachas François, Łusakowska Anna, Carrera Paola, Meininger Vincent, Battistini Stefania, Kwieciński Hubert, Zekanowski Cezary
Laboratory of Neurogenetics, Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawińskiego 5, Warsaw, Poland.
Amyotroph Lateral Scler. 2012 Jan;13(1):132-6. doi: 10.3109/17482968.2011.600316. Epub 2011 Aug 30.
Mutations in the superoxide dismutase-1 (SOD1) gene have been found in 12-23% of patients with a diagnosis of ALS. Here we describe a large ALS Polish family with a branch in France, carrying a G41S mutation in the SOD1, and characterized by an early onset of the disease and extremely short survival time. The mutation has been initially detected in Italian ALS families with common founder effect. However, in the Polish population the G41S mutation most probably originated from an independent mutation event, as indicated by haplotype analysis. Collected data support the hypothesis that a SOD1 mutation is not the sole factor determining the clinical ALS phenotype.
在诊断为肌萎缩侧索硬化症(ALS)的患者中,有12% - 23%被发现超氧化物歧化酶1(SOD1)基因发生突变。在此,我们描述了一个来自波兰的大型ALS家族,该家族在法国有一个分支,其SOD1基因携带G41S突变,其特征为疾病发病早且存活时间极短。该突变最初在具有共同奠基者效应的意大利ALS家族中被检测到。然而,单倍型分析表明,在波兰人群中,G41S突变很可能源于一次独立的突变事件。收集到的数据支持这样一种假说,即SOD1突变并非决定ALS临床表型的唯一因素。